Reply To: SARS cov2 and Covid 19

Home Forums Discussion Forum SARS cov2 and Covid 19 Reply To: SARS cov2 and Covid 19



“If the end points are reached the two arms of the trial are unblinded and the interim results published.”

And what are these end points? …

First, a relative risk reduction is being reported, not absolute risk reduction, which appears to be less than 1%. Second, these results refer to the trials’ primary endpoint of covid-19 of essentially any severity, and importantly not the vaccine’s ability to save lives, nor the ability to prevent infection, nor the efficacy in important subgroups (e.g. frail elderly). Those still remain unknown. Third, these results reflect a time point relatively soon after vaccination, and we know nothing about vaccine performance at 3, 6, or 12 months, so cannot compare these efficacy numbers against other vaccines like influenza vaccines (which are judged over a season). Fourth, children, adolescents, and immunocompromised individuals were largely excluded from the trials, so we still lack any data on these important populations.

“There is nothing irregular in how these trials were conducted.”

You are writing in the past tense as though these trials are completed. They are not.